Avoro Capital Advisors LLC

Avoro Capital Advisors LLC is a New York-based investment firm specializing in the life sciences sector, with a dedicated focus on supporting the advancement of emerging biotechnology companies across the United States. The firm provides both financial and intellectual support throughout the investment lifecycle, aiming to identify unique or mispriced opportunities and address unmet medical needs through scientific breakthroughs.

Established in 2010, Avoro Capital has a history of substantial investments, including a $95 million Series C funding round in Monte Rosa Therapeutics in 2021. The firm's portfolio construction strategy emphasizes vigilant risk management, incorporating tactical and fundamental hedges, and carefully considers sizing and liquidity.

Avoro Capital's approach is characterized by intellectual curiosity and a commitment to dissecting complex situations, fostering an environment where large pharmaceutical firms actively seek growth opportunities via partnerships and mergers and acquisitions. This proactive strategy enhances the value of assets with differentiating characteristics, aligning with the firm's core philosophy of supporting progress in the biotechnology sector.